Skip to main content
. 2019 May 2;28(14):2449–2457. doi: 10.1093/hmg/ddz061

Table 2.

Independent SNPs associated with beverage consumption that met pre-specified replication criteria1

Locus Chr:pos dbSNP ID Closest gene EA/RA EAF Stage 1 (n = 85 852) Stage 2 (n = 39 924) Joint meta-analysis
Beta2 SE2 P Beta2 SE2 P Beta2 SE2 P N
Total bitter beverages
2p23.3 2:27730940 rs1260326 GCKR C/T 0.61 1.05 0.18 2.87E-09 1.63 0.45 3.46E-04 1.13 0.16 8.33E-12 125 776
4q22.1 4:89039082 rs1481012 ABCG2 A/G 0.89 1.42 0.27 2.09E-07 2.10 0.71 3.49E-03 1.50 0.25 3.82E-09 125 776
7p21.1 7:17284577 rs4410790 AHR C/T 0.63 2.58 0.18 2.36E-46 3.71 0.46 3.36E-15 2.73 0.17 7.09E-59 125 776
7q11.23 7:75616105 rs17685 POR A/G 0.28 1.35 0.19 2.71E-12 2.50 0.50 7.64E-07 1.50 0.18 1.02E-16 125 776
15q24.1 15:75027880 rs2472297 CYP1A1/2 T/C 0.26 3.42 0.19 6.58E-67 3.42 0.54 4.74E-10 3.43 0.18 1.81E-75 125 776
Bitter non-alcoholic beverages
1q21.3 1:150956128 rs12405726 ANXA9 A/G 0.35 1.05 0.18 5.90E-09 1.49 0.45 1.01E-03 1.12 0.17 3.50E-11 125 776
7p21.1 7:17284577 rs4410790 AHR C/T 0.63 2.97 0.18 2.94E-61 3.87 0.44 1.16E-17 3.10 0.16 1.39E-76 125 776
7p21.1 7:17401027 rs7791070 KCCAT333 T/C 0.76 1.67 0.20 2.44E-16 2.33 0.52 8.63E-06 1.76 0.19 2.09E-20 125 776
7q11.23 7:73047551 rs35855035 MLXIPL T/C 0.22 1.05 0.21 4.71E-07 1.47 0.53 5.43E-03 1.11 0.19 1.15E-08 125 776
7q11.23 7:75615006 rs1057868 POR T/C 0.29 1.71 0.19 5.17E-19 2.41 0.47 5.50E-07 1.81 0.18 3.95E-24 125 776
15q24.1 15:75027880 rs2472297 CYP1A1/2 T/C 0.26 3.93 0.19 1.30E-87 3.88 0.52 3.04E-13 3.93 0.18 2.20E-99 125 776
22q13.2 22:41958862 rs9607819 CSDC2 G/C 0.81 1.29 0.22 4.56E-09 1.45 0.54 7.43E-03 1.31 0.20 1.20E-10 125 776
Bitter alcoholic beverages 3
2p23.3 2:27730940 rs1260326 GCKR C/T 0.61 1.41 0.11 2.78E-34 0.87 0.24 2.87E-04 1.31 0.10 2.52E-36 376 372
4p14 4:39414993 rs11940694 KLB G/A 0.60 1.34 0.12 1.07E-30 0.92 0.24 1.37E-04 1.26 0.10 2.25E-33 376 372
4q23 4:100239319 rs1229984 ADH1B C/T 0.98 10.43 0.38 1.08E-151 3.60 0.64 2.48E-08 8.60 0.32 2.00E-142 376 372
11p11.2 11:47722819 rs7935528 AGBL2 A/G 0.45 0.75 0.11 2.83E-11 0.71 0.24 3.12E-03 0.74 0.10 3.33E-13 376 372
Coffee 4
1q25.2 1:177873210 rs574367 SEC16B T/G 0.21 0.99 0.19 2.61E-07 1.62 0.58 5.19E-03 1.05 0.18 8.06E-09 375 833
2p25.3 2:631606 rs10865548 TMEM18 G/A 0.83 1.52 0.21 2.35E-13 1.66 0.59 5.11E-03 1.54 0.19 4.46E-15 375 833
2p23.3 2:27730940 rs1260326 GCKR C/T 0.61 1.31 0.16 2.92E-16 1.79 0.46 1.22E-04 1.36 0.15 2.62E-19 375 833
7p21.1 7:172776925 rs117692895 AHR C/G 0.01 4.01 0.71 2.60E-08 7.12 2.23 1.86E-03 4.29 0.67 4.13E-10 374 046
7p21.1 7:17284577 rs4410790 AHR C/T 0.63 3.85 0.16 4.73E-121 4.63 0.47 4.20E-22 3.94 0.15 5.59E-141 375 833
7p21.1 7:17334899 rs4719497 AHR T/C 0.87 1.12 0.23 1.10E-06 1.81 0.67 7.27E-03 1.20 0.22 4.23E-08 375 833
7p21.1 7:17443199 rs12699844 KCCAT333 C/T 0.47 1.22 0.16 1.16E-14 1.37 0.46 2.93E-03 1.24 0.15 1.35E-16 375 833
7p21.1 7:17562952 rs73073176 LOC101927630 C/T 0.87 2.30 0.23 1.54E-22 2.34 0.69 8.47E-04 2.31 0.22 5.56E-25 375 833
7q11.23 7:73037956 rs34060476 MLXIPL G/A 0.13 1.79 0.23 8.05E-15 2.78 0.68 5.23E-05 1.89 0.22 5.06E-18 375 833
7q11.23 7:75615006 rs1057868 POR T/C 0.29 1.88 0.17 2.44E-27 2.72 0.50 1.09E-07 1.97 0.16 5.26E-33 375 833
11q12.1 11:56272114 rs597045 OR8U8 A/T 0.69 1.02 0.17 2.86E-09 1.41 0.50 4.98E-03 1.07 0.16 6.62E-11 375 833
14q12 14:33075243 rs1956218 AKAP6 G/A 0.56 0.77 0.16 1.27E-06 1.30 0.45 4.52E-03 0.82 0.15 3.62E-08 375 833
15q24.1 15:75027880 rs2472297 CYP1A1/2 T/C 0.27 4.54 0.18 8.28E-141 4.57 0.56 8.69E-16 4.54 0.17 5.19E-155 375 833
18q21.32 18:57808978 rs66723169 MC4R A/C 0.23 1.41 0.19 3.32E-14 1.91 0.54 4.82E-04 1.47 0.18 9.88E-17 375 833
22q11.23 22:24747031 rs2330783 SPECC1L-ADORA2A G/T 0.99 4.44 0.67 6.20E-11 5.25 1.91 6.72E-03 4.53 0.63 1.57E-12 375 833
SSBs
16q12.2 16:53809123 rs55872725 FTO C/T6 0.59 0.96 0.15 1.29E-10 1.28 0.21 6.36E-10 1.07 0.12 1.05E-18 125 776

Chr:pos, chromosome:position. EA, effect allele; EAF, effect allele frequency; RA, reference allele; SE, standard error.

1Independent SNPs were identified using conditional analysis. Independent SNPs with P < 5 × 10−6 in stage 1 were replicated if (i) stage 2 P < 0.01; (ii) joint stage 1 and stage 2 meta-analysis P < 5 × 10−8; and (iii) consistent direction of effect.

2Betas and SEs are interpreted as % change per allele.

3 n = 336 448 in stage 1.

4 n = 335 909 in stage 1.

5 n = 38 137 in stage 2.

6T allele is the BMI increasing allele.